CUTANEOUS T CELL LYMPHOMA (CTCL)
Clinical trials for CUTANEOUS T CELL LYMPHOMA (CTCL) explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS T CELL LYMPHOMA (CTCL) trials appear
Sign up with your email to follow new studies for CUTANEOUS T CELL LYMPHOMA (CTCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody targets Hard-to-Treat skin cancer in first human trial
Disease control Not yet recruitingThis early-phase trial tests a new drug, DT-7012, for people with advanced cutaneous T-cell lymphoma (CTCL) that has not responded to other treatments. The drug is an antibody designed to seek out and destroy cancer cells in the skin while also helping the immune system fight the…
Matched conditions: CUTANEOUS T CELL LYMPHOMA (CTCL)
Phase: EARLY_PHASE1 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 17, 2026 05:49 UTC
-
New hope for skin lymphoma: drug after transplant may keep cancer away
Disease control Not yet recruitingThis study tests whether giving brentuximab vedotin (a targeted drug) right after a stem cell transplant can prevent early relapse in people with advanced cutaneous T-cell lymphoma (CTCL). About 84 adults aged 18–70 with CD30-positive mycosis fungoides who have already tried at l…
Matched conditions: CUTANEOUS T CELL LYMPHOMA (CTCL)
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 17, 2026 05:34 UTC
-
New hope for Hard-to-Treat skin cancer: safer chemo combo enters trials
Disease control Not yet recruitingThis study tests a new combination of drugs (aclarubicin plus cyclophosphamide, vincristine, and prednisone, called CAOP) in 37 people aged 60+ with relapsed or refractory cutaneous T-cell lymphoma (CTCL), a rare skin cancer. The goal is to find the safest dose and see if it shri…
Matched conditions: CUTANEOUS T CELL LYMPHOMA (CTCL)
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated May 07, 2026 18:41 UTC